Skip to main content
Premium Trial:

Request an Annual Quote

MS Vision to Sell, Service Ionalytics Selectra Tech for ABI, MDS Proteomics Platform

NEW YORK, Nov. 19 (GenomeWeb News) - MS vision will serve as Ionalytics' European agent, providing sales and service support for the proteomics company's Selectra technology.

 

Under the agreement, MS Vision will market Ionalytics Selectra in Europefor the Applied Biosystems/MDS Sciex API 300, 365 and 3000.

 

According to Ionalytics, Selectra enhances mass-spectrometer performance by providing an additional dimension of ion separation. Based on FAIMS technology, the Selectra transmits a targeted subset of ions into a mass spectrometer, resulting in improved detection limits, increased selectivity and increased throughput.

 

Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.